Circulating biomarkers to monitor cancer progression and treatment
Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Due to intratumoral heterogeneity and selection of s...
| 主要な著者: | , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Elsevier
2016-01-01
|
| シリーズ: | Computational and Structural Biotechnology Journal |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2001037016300113 |